Results 13,261-13,280 of 21,090 for speaker:Alan Kelly

Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)

Alan Kelly: They are all grouped.

Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)

Alan Kelly: I also support the removal of the word "serious". Speaking to my amendment, my advice is that the word "avert" in section 10(1)(c) is too absolute in its meaning and it needs to be examined. That is why I have suggested, as has Deputy O'Reilly, that we put in "to avert or mitigate". I do not understand why that could not be allowed. We have looked at the measure in different ways and the...

Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)

Alan Kelly: I will not be supporting the amendment. With all due respect, I cannot even see why it is being brought forward in the way it is. I would see the provision as a fundamental change and think it would change everything. I presume that in the advice the Minister has been given and the consultation he has had with medics he has been told that they would not see that they would be able to...

Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)

Alan Kelly: That is enough for me.

Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)

Alan Kelly: That clears up the matter.

Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)

Alan Kelly: I move amendment No. 53:In page 9, line 15, after “avert” to insert “or mitigate”. I will withdraw the amendment on the basis that the Minister will come back to us, having considered it and taken legal advice. Our strong advice is that it is too absolute and needs to be changed.

Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)

Alan Kelly: I move amendment No. 56:In page 9, to delete lines 23 to 28 and substitute the following:"(4) The obstetrician referred to in paragraph (a) of subsection (2) shall make such arrangements as he or she shall deem to be necessary for the carrying out as soon as may be of the termination of pregnancy to which the certification referred to in subsection (3) relates.". This brings us back to an...

Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)

Alan Kelly: The Chair may withdraw my name as my query has been clarified.

Written Answers — Department of Health: National Drugs Strategy Budget (8 Nov 2018)

Alan Kelly: 160. To ask the Minister for Health the process used to make a decision to increase or decrease an amount (details supplied); if this figure will increase for 2019; and his role in determining same. [46291/18]

Written Answers — Department of Health: National Drugs Strategy Budget (8 Nov 2018)

Alan Kelly: 161. To ask the Minister for Health the process used to make a decision to increase or decrease an amount (details supplied); the provision for drug and alcohol task forces within this figure; if the figure for task forces within this heading will increase for 2019; and his role in determining same. [46292/18]

Public Accounts Committee: Business of Committee (8 Nov 2018)

Alan Kelly: The Chairman is too doctrinal in his definition.

Public Accounts Committee: Business of Committee (8 Nov 2018)

Alan Kelly: I will do that.

Public Accounts Committee: Business of Committee (8 Nov 2018)

Alan Kelly: Damien McCallion, the chap with responsibility for that area, is here.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: I have a lot to get through, so I would appreciate it if the witnesses can be concise. The table Mr. Breen provided contained information on claims and litigation. On CervicalCheck it tells us that there are 73 claims which are active and which have not been settled, five claims have been settled, one claim has closed and there are six potential claims. How many cases have been settled due...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: This information is very important. There are 73 active claims and six further potential claims. Of the cases that have settled because of negligence, is the witness aware of the reasons for their being settled?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: I appreciate that and I understand that, but I wanted to get a sense of it for the public because there has been a lot of commentary on this matter. We need to bring this debate back a bit and get a sense of where the division is from the point of view of the witness, who is representing the State. It is important that people have that information. Cases have been settled or closed where...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: The witness just accepts that the laboratories accept that.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: It is an important point that I do not think we have discussed before.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: That is an important point. The distinction between non-disclosure and negligence or potential negligence will become more of an issue as we go through these cases. As the cases progress, we will get more transparency on that. Is that fair to say?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: My colleagues have referenced the next matter I want to discuss. Much attention has been given to the length of time it is taking for the women affected and their solicitors to get the slides from the laboratories. One solicitor has very publicly said that three clients were waiting more than three months for their slides after having agreed to the protocol release of the slides, and we...